TITLE

Smoking, Smoking Status, and Risk for Symptomatic Peripheral Artery Disease in Women

AUTHOR(S)

Conen, David; Everett, Brendan M.; Kurth, Tobias; Creager, Mark A.; Buring, Julie E.; Ridker, Paul M.; Pradhan, Aruna D.

PUB. DATE

June 2011

SOURCE

Annals of Internal Medicine;6/7/2011, Vol. 154 Issue 11, p719

SOURCE TYPE

Academic Journal

DOC. TYPE

Article

ABSTRACT

Background: Smoking has a well-documented detrimental effect on risk for myocardial infarction and stroke, but less information is available regarding peripheral artery disease (PAD), particularly among women. Objective: To prospectively assess the association of current smoking status, cumulative smoking exposure, and smoking cessation with incident symptomatic PAD in women. Design: Prospective cohort study. Setting: U.S. female health care professionals in the Women's Health Study. Participants: 39 825 women with no cardiovascular disease who were prospectively followed for a median of 12.7 years. Measurements: Incidence of symptomatic PAD. Cox proportional hazards models were used to compare PAD risk across smoking categories. Results: 178 confirmed PAD events occurred. Across the 4 smoking categories (never, former, <15 cigarettes/d, and ⩾15 cigarettes/d), age-adjusted incidence rates were 0.12, 0.34, 0.95, and 1.63 per 1000 person-years of follow-up, respectively. Multivanate adjustment had little effect on this relationship (adjusted hazard ratios [HRs], 3.14 [95% Cl, 2.01 to 4.90], 8.93 [Cl, 5.02 to 15.89], and 16.95 [Cl, 10.77 to 26.67], respectively, vs. women who never smoked). Additional adjustment for high-sensitivity C-reactive protein and soluble intercellular adhesion molecule-i levels among women with available blood samples (28 314 participants, 117 events) attenuated risk estimates (HR. 5.58 [I, 2.61 to 11.93] for smoking <15 cigarettes/d and 9.52 [Cl, 5.17 to 17.53] for smoking ⩾15 cigarettes/d). Lifetime exposure showed a strong dose-response relationship; fully adjusted HRs for smoking abstinence of fewer than 10, 10 to 29, and 30 or more pack-years were 2.52 (Cl, 1.49 to 4.25), 6.75 (Cl, 4.33 to 10.52), and 11.09 (Cl, 6.94 to 17.72), respectively. Compared with current smokers, the adjusted HRs for fewer than 10 years, 10 to 20 years, more than 20 years, or lifelong abstinence were 0.39 (Cl, 0.24 to 0.66), 0.28 (Cl, 0.17 to 0.46), 0.16 (Cl, 0.10 to 0.26), and 0.08 (Cl, 0.05 to 0.12), respectively. Limitation: The use of symptomatic PAD as the a priori primary end point excludes asymptomatic disease. Conclusion: Among initially healthy women, smoking is a potent risk factor for symptomatic PAD and was associated with subclinical inflammation. Smoking cessation substantially reduces risk for PAD, but an increased occurrence of PAD persists even among former smokers who maintain abstinence.

ACCESSION #

62807874

 

Related Articles

• Predictors of Smoking Cessation and Relapse in Older Adults. Salive, Marcel E.; Cornoni-Huntley, Joan; LaCroix, Andrea Z.; Ostfeld, Adrian M.; Wallace, Robert B.; Hennekens, Charles H. // American Journal of Public Health;Sep92, Vol. 82 Issue 9, p1268 

  We examined longitudinal changes in smoking behavior among older adults in three community cohorts of the Established Populations for Epidemiologic Studies of the Elderly. Smoking prevalence declined from 15% at baseline to 9% during 6 years of follow-up. Annual smoking cessation and relapse...

• Quitting smoking brings immediate health and economic benefits.  // Modern Medicine;Nov97, Vol. 65 Issue 11, p60 

  Presents an abstract of the research `Shortterm Economic and Health Benefits of Smoking Cessation: Myocardial Infarction and Stroke,' by J.M. Lightwood and S.A. Glantz and `Curbing the Tobacco Menace (Editorial),' by W.B. Kannel published in `Circulation,' dated August 19, 1997.

• Secondary prevention in survivors of myocardial infarction. Arntzenius, A.C.; Breddin, K.; Brouster, J.P.; Denolin, H.; Dorossiev, D.L.; Epstein, F.H.; Froment, A.; Goto, Y.; Greten, H.; Hirschhaut, E.; Kellermann, J.J.; Konig, K.; Kornitzer, M.; Lamm, G.; Lasch, Hans-Gotthard; Mancini, M.; Mulcahy, R.; Pyorala, K. // British Medical Journal (Clinical Research Edition);3/14/1981, Vol. 282 Issue 6267, p894 

  Focuses on the secondary prevention of myocardial infarction survivors in Germany. Recommendation of dynamic exercise as a rehabilitative measure following myocardial infarction; Benefits of smoking cessation programs; Importance of diet in patients after myocardial infarction.

• Quitting Smoking After Heart Attack Can Add More Years to Life.  // Mayo Clinic Women's Health Source;Jun2010, Vol. 14 Issue 6, p3 

  The article reports on a study in the December 15, 2009 issue of the "Journal of the American College of Cardiology" that show smokers who quit the habit after a heart attack are less likely to die.

• The �Million Hearts� Initiative � Preventing Heart Attacks and Strokes. Frieden, Thomas R.; Berwick, Donald M. // New England Journal of Medicine;9/29/2011, Vol. 365 Issue 13, pN.PAG 

  The article focuses on the Million Hearts initiative, which was launched by the U.S. Department of Health and Human Services (DHHS) in September 2011 to prevent one million heart attacks and strokes over the next 5 years through proven, effective and inexpensive interventions. Such interventions...

• Smoking cessation. Treasure, Tom; Treasure, Janet // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;1/30/2010, Vol. 340 Issue 7740, p223 

  The authors emphasize the importance of quitting smoking as the habit is a key contributor to common diseases, including heart attack, stroke, and chronic obstructive pulmonary disease. They discuss a meta-analysis of the effect of continued smoking on smokers. They argue that quitting smoking...

• On the relationship between smoking bans and incidence of acute myocardial infarction. Gasparrini, Antonio; Gorini, Giuseppe; Barchielli, Alessandro // European Journal of Epidemiology;Oct2009, Vol. 24 Issue 10, p597 

  During the last few years several studies have reported a substantial reduction of acute myocardial infarction (AMI) in the general population few months after the enforcement of comprehensive smoking bans. We reviewed the consistency and plausibility of this association, investigating the...

• Kiwi Champix users have heart attacks. Cameron, Amanda // New Zealand Doctor;7/13/2011, p4 

  The article reports that 12 New Zealanders who are taking Champix for smoking cessation have experienced a heart attack in the last four years as of July 2011, the safety of which is being re-evaluated in light of recent research connecting it to an increased risk of serious cardiovascular events.

• Phenomena, comment and notes. Wiley Jr., John P. // Smithsonian;Apr89, Vol. 20 Issue 1, p32 

  Discusses how the author quit smoking after having a heart attack. Account of the angiogram process; Physiological effects of smoking; Improvement in the author's health after giving up smoking; Diseases associated with smoking.

Read the Article